MalnutritionGAINNCT05544318
Green Approach to Improved Nutritional Support for Cancer Patients
A study testing Diatary advices in people with Malnutrition, run by University of Oslo at 1 site in Norway.
Trial summary
In this study, we aim to reduce the burden of malnutrition in cancer patients by implementing and evaluating an improved nutritional support, using digital communication and registration tools during the clinical pathway. Read more about this study
- Who is it for?
- Ages 18 years and older
- Conditions the study is for
- Malnutrition
- What is being tested?
- Diatary advices
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 130 participants
- Where
- 1 siteNorway
- Study dates
- 1 Oct 2022to 30 Apr 2026
- Phase
- Interventional
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- All sexes
- No healthy volunteers
- Adult, Older adult
Who may be able to join
- Adults with primary:
- gynaecologic cancer with planned radiation therapy (ca. cervix)
- colorectal cancer
- lymphomas
Who cannot join
- Exclusion criteria are defined as patients admitted with TNM stage 4
- Terminal condition (life expectancy < 6 months).
Trial locations and contacts
1 site in 1 country.
About this study
In this study, we aim to reduce the burden of malnutrition in cancer patients by implementing and evaluating an improved nutritional support, using digital communication and registration tools during the clinical pathway. The project targets a group of patients with a high frequency of malnutrition, due to cancer and the subsequent therapy, where knowledge on the efficient and cost-effective treatment is scarce. The effect of the improved nutrition support will be evaluated in a randomised controlled trial, and the primary endpoint is the prevalence of malnutrition. The long-term goal is to benefit the patients by increasing the completion rate of cancer treatment, reducing the infection rate, need for antibiotics, the total length of hospital stays and number of non-elective re-admissions, and thus increasing the patients' quality of life and survival. The project will be patient-orientated and result in a sustainable approach for the management of malnutrition.
Read the detailed description
WP1. Effect of the improved nutritional support
Task 1.1 Recruitment of participants
Consenting, eligible participants will be screened for malnutrition using NRS-2002 by the PhD student, and randomised to intervention or control group stratified for malnutrition risk. All participants will go through a baseline assessment at the Center for clinical nutrition. Participants in the intervention group will be scheduled for a first dietitian visit at the nutrition outpatient clinic at OUH, at the same day as the baseline assessment.
Task 1.2 Intervention
Included in the green approach to improved nutritional support are:
- Individual dietitian support for patients at risk
- Self-monitoring of food intake and weight
Digital communication tools to enable frequent follow-up during the cancer treatment. Patients at risk of malnutrition will be given individual goals on energy- and protein intake, weight and body composition. The goals will be converted to specific, measurable and acceptable guidance according to the motivational interview techniques.
Participants will be provided with a tablet computer to monitor dietary intake using the FoodCapture system, intended for nutrition monitoring and follow-up. The interface of FoodCapture consists of an app for mobile devices and a website and includes functions to record, evaluate and document nutrition and generate reports for health professionals.
The technical development of the FoodCapture device is performed by the University Centre for Information Technology (USIT) at the University of Oslo. A web form is used for data flow in the app and data are sent to 'Services for sensitive data' (Tjenester for sensitive data, TSD), both hosted by USIT. Information registered in the FoodCapture app and the recordings of dietary intake are sent encrypted through the web form to TSD. The TSD system is a high-security private cloud eInfrastructure to process and store sensitive research data. It is included in NorStore, the Norwegian national infrastructure for handling and storing scientific data (21).
All data recorded in the FoodCapture app are continuously sent to TSD. In cases of technical problems or loss of internet connection, the data are stored temporarily in an encrypted format before being sent to TSD when the device resumes an internet connection.
To gain access to the FoodCapture web report, healthcare professionals have to complete an access form, that has to be approved by an administrator. Log-in to the webserver is done through the common log-in solution to public services in Norway: ID-porten and authentication is sent to the TSD server to verify access to the web report. The FoodCapture tool is CE marked as a medical device class 1 and registered at the Norwegian Medicines Agency.
Self-monitoring of weight will be facilitated by a digital scale, with a wireless connection to the tablet computer. All data from the digital scale will be transferred to "Services for Sensitive Data" (TSD) and then becomes available for the dietitian, who contacts patients in need of support.
The intervention includes physical and digital follow-up sessions (telephone or video-meetings) with the patient's personal dietician, who will be the main responsible for the nutritional support throughout the clinical pathway. The patient follow-up frequency will be customised, depending on the situation and the patient's needs, but will at a minimum include one physical visits in addition to digital follow-ups during the first 6 months.
Follow-up visits. All participants will be followed up after 6 months to assess malnutrition status. The 12 months follow-up visit is included to evaluate the long-term effect on quality of life and survival.
Sample size: Based on our previous experience with the effect of FoodCapture, we expect a difference in the prevalence of malnutrition of 17 percentage points after 6 months. With a statistical power of 80 % and a significance level of 5 %, we will need a total of 104 patients: 52 in each group to detect expected difference. To allow for a 20 % drop-out, we will recruit 130 participants, and anticipate that the recruitment will last for about 7 months.
WP2. Implementation of improved nutritional support
WP2 will be conducted in close cooperation with the users, including patients, health care professionals and next-of-kin. An implementation study will be performed before and in parallel with the effect study (WP1), using a mixed-method approach with qualitative and quantitative measurements. This WP consists of three tasks:
Task 2.1 First, we will explore the readiness and potential barriers and facilitators of the improved nutritional support by using the Consolidated Framework for Implementation Research. Data will be gathered in focus group discussions.
Task 2.2 The identified barriers and facilitators will be used to create a plan for the implementation of the improved nutritional support. The plan will include implementation strategies, like methods for stakeholder engagement, management support, training and follow-up.
Task 2.3 Finally, we will study the implementation outcomes as described by Proctor et al (30) and explore how the nutritional support is perceived among patients and their next-of-kins. This will include acceptability and practical use of the nutritional support and compatibility with the clinical pathway, if the intervention was delivered as intended, and how the intervention can reach sustainability in the future. Data will be gathered using online questionnaires, technical log-data, focus group discussions and individual interviews
WP3. Economic evaluation on nutritional support
WP3 will be conducted in close cooperation with experts on health economics at the Clinical Trial Unit at OUH. Economic evaluation is defined as the comparison of alternative options in terms of cost and consequences (outcomes).
To calculate the economic impact of the improved nutritional support, based on the results of WP1. We will perform a cost-utility analysis of the nutritional support compared to standard routine care in cancer patients, taking a societal perspective. The generic outcome is Quality adjusted life-years (QALYs) measured by the generic instrument EQ-5D-5L. In order to generate QALYs, health utilities are needed. Utilities are preference weights, measured on a scale from 0 (dead) and 1 (full health). Data will be collected through self-reported measures and electronic patient records, and the health economic analysis will include following costs:
Intervention related costs, mainly related to intervention implementation (introduction to health care personnel and patients, maintenance (software and security updates) and personnel costs due to follow-up.
Health care costs/direct costs, mainly related to use of health care services (including primary care; general practitioner, physical therapy, psychology visits, secondary care; hospitalization, readmission, outpatient visits, use of antibiotics, enteral and parenteral nutrition products.
Societal costs/indirect costs, including work absence (i.e., productivity loss).
- Conditions
- Malnutrition
- Being tested
- Diatary advices
- Medical subject headings
- Malnutrition
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Diatary advicesOther
Also called Usual care
Advice regarding energy, protein and nutrient intake during cancer treatment
| Study group | Role | What they receive |
|---|---|---|
| Intervention | Experimental | Extra nutritional support Receives: Other: Diatary advices |
| Control | No intervention | Usual care |
What is being measured
The primary outcome is the main question the study is designed to answer.
Malnutrition
Measured by PG-SGA
Measured: After 6 months
Secondary outcomes (11)
Malnutrition by GLIM
Malnutrition measured by the objective method developed by the Global Leadership Initiative on Malnutrition (GLIM). The GLIM-criteria also categories the participants i three groups: Well-nourished, moderate malnutrition and severe malnutrition.
Measured: 6 month
Other clinical outcomes
Cancer treatment completion rate
Measured: 6 months
Survival
From electronic medical records
Measured: 12 months
Health-related quality of life
Questionnaires Core 30 (QLQ-C30)
Measured: 6 and 12 months
Cancer specific quality of life
EQ-5D-5L
Measured: 6 and 12 months
Health costs
To be estimated
Measured: 12 months
Appreciation by health care professionals and patients
By interviews
Measured: 6 months
Infection rate
Number
Measured: 6 months
Need for antibiotics
Number
Measured: 6 months
Length of hospital stay
Days
Measured: 6 months
Re-admissions
Number
Measured: 6 and 12 months
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted16 Sep 2022
- Study start1 Oct 2022
- Primary completion31 Oct 2025 (estimated)
- Study completion30 Apr 2026 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (1)Papers the sponsor has linked to this study.
- Other trials for MalnutritionStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Health services research
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Model description
- Randomised controlled trial
- Masking
- None (open label)
- Enrolment
- 130 participants (estimated)
Sponsor and investigators
- Lead sponsor
- University of Oslo
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Christine Henriksen, University of Oslo
- Investigators
- Christine Henriksen, PhD, Principal investigator, University of Oslo
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT05544318
- Sponsor's protocol ID
- 267889
- Acronym
- GAIN
- Status last verified
- Apr 2025
- First submitted
- 8 Sep 2022
- Last updated
- 8 Sep 2025
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Publications
Beichmann B, Henriksen C, Paur I, Paulsen MM. Barriers and facilitators of improved nutritional support for patients newly diagnosed with cancer: a pre-implementation study. BMC Health Serv Res. 2024 Jul 15;24(1):815. doi: 10.1186/s12913-024-11288-2.
PubMed 39010098
Study at a glance
From the registry record, last updated by the sponsor on 8 Sep 2025. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Green Approach to Improved Nutritional Support for Cancer Patients
- ClinicalTrials.gov ID
- NCT05544318
- Acronym / sponsor ID
- GAIN / 267889
- Conditions
- Malnutrition
- Study type
- Interventional
- Recruitment status
- Active, not recruiting
- Enrolment
- 130 participants (estimated)
- Lead sponsor
- University of OsloUniversity, hospital or other
- Study start
- 1 Oct 2022 (actual)
- Primary completion
- 31 Oct 2025 (estimated)
- Study completion
- 30 Apr 2026 (estimated)
- First posted
- 16 Sep 2022 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
In this study, we aim to reduce the burden of malnutrition in cancer patients by implementing and evaluating an improved nutritional support, using digital communication and registration tools during the clinical pathway. The project targets a group of patients with a high frequency of malnutrition, due to cancer and the subsequent therapy, where knowledge on the efficient and cost-effective treatment is scarce. The effect of the improved nutrition support will be evaluated in a randomised controlled trial, and the primary endpoint is the prevalence of malnutrition. The long-term goal is to benefit the patients by increasing the completion rate of cancer treatment, reducing the infection rate, need for antibiotics, the total length of hospital stays and number of non-elective re-admissions, and thus increasing the patients' quality of life and survival. The project will be patient-orientated and result in a sustainable approach for the management of malnutrition.
Detailed description
WP1. Effect of the improved nutritional support
Task 1.1 Recruitment of participants
Consenting, eligible participants will be screened for malnutrition using NRS-2002 by the PhD student, and randomised to intervention or control group stratified for malnutrition risk. All participants will go through a baseline assessment at the Center for clinical nutrition. Participants in the intervention group will be scheduled for a first dietitian visit at the nutrition outpatient clinic at OUH, at the same day as the baseline assessment.
Task 1.2 Intervention
Included in the green approach to improved nutritional support are:
- Individual dietitian support for patients at risk
- Self-monitoring of food intake and weight
Digital communication tools to enable frequent follow-up during the cancer treatment. Patients at risk of malnutrition will be given individual goals on energy- and protein intake, weight and body composition. The goals will be converted to specific, measurable and acceptable guidance according to the motivational interview techniques.
Participants will be provided with a tablet computer to monitor dietary intake using the FoodCapture system, intended for nutrition monitoring and follow-up. The interface of FoodCapture consists of an app for mobile devices and a website and includes functions to record, evaluate and document nutrition and generate reports for health professionals.
The technical development of the FoodCapture device is performed by the University Centre for Information Technology (USIT) at the University of Oslo. A web form is used for data flow in the app and data are sent to 'Services for sensitive data' (Tjenester for sensitive data, TSD), both hosted by USIT. Information registered in the FoodCapture app and the recordings of dietary intake are sent encrypted through the web form to TSD. The TSD system is a high-security private cloud eInfrastructure to process and store sensitive research data. It is included in NorStore, the Norwegian national infrastructure for handling and storing scientific data (21).
All data recorded in the FoodCapture app are continuously sent to TSD. In cases of technical problems or loss of internet connection, the data are stored temporarily in an encrypted format before being sent to TSD when the device resumes an internet connection.
To gain access to the FoodCapture web report, healthcare professionals have to complete an access form, that has to be approved by an administrator. Log-in to the webserver is done through the common log-in solution to public services in Norway: ID-porten and authentication is sent to the TSD server to verify access to the web report. The FoodCapture tool is CE marked as a medical device class 1 and registered at the Norwegian Medicines Agency.
Self-monitoring of weight will be facilitated by a digital scale, with a wireless connection to the tablet computer. All data from the digital scale will be transferred to "Services for Sensitive Data" (TSD) and then becomes available for the dietitian, who contacts patients in need of support.
The intervention includes physical and digital follow-up sessions (telephone or video-meetings) with the patient's personal dietician, who will be the main responsible for the nutritional support throughout the clinical pathway. The patient follow-up frequency will be customised, depending on the situation and the patient's needs, but will at a minimum include one physical visits in addition to digital follow-ups during the first 6 months.
Follow-up visits. All participants will be followed up after 6 months to assess malnutrition status. The 12 months follow-up visit is included to evaluate the long-term effect on quality of life and survival.
Sample size: Based on our previous experience with the effect of FoodCapture, we expect a difference in the prevalence of malnutrition of 17 percentage points after 6 months. With a statistical power of 80 % and a significance level of 5 %, we will need a total of 104 patients: 52 in each group to detect expected difference. To allow for a 20 % drop-out, we will recruit 130 participants, and anticipate that the recruitment will last for about 7 months.
WP2. Implementation of improved nutritional support
WP2 will be conducted in close cooperation with the users, including patients, health care professionals and next-of-kin. An implementation study will be performed before and in parallel with the effect study (WP1), using a mixed-method approach with qualitative and quantitative measurements. This WP consists of three tasks:
Task 2.1 First, we will explore the readiness and potential barriers and facilitators of the improved nutritional support by using the Consolidated Framework for Implementation Research. Data will be gathered in focus group discussions.
Task 2.2 The identified barriers and facilitators will be used to create a plan for the implementation of the improved nutritional support. The plan will include implementation strategies, like methods for stakeholder engagement, management support, training and follow-up.
Task 2.3 Finally, we will study the implementation outcomes as described by Proctor et al (30) and explore how the nutritional support is perceived among patients and their next-of-kins. This will include acceptability and practical use of the nutritional support and compatibility with the clinical pathway, if the intervention was delivered as intended, and how the intervention can reach sustainability in the future. Data will be gathered using online questionnaires, technical log-data, focus group discussions and individual interviews
WP3. Economic evaluation on nutritional support
WP3 will be conducted in close cooperation with experts on health economics at the Clinical Trial Unit at OUH. Economic evaluation is defined as the comparison of alternative options in terms of cost and consequences (outcomes).
To calculate the economic impact of the improved nutritional support, based on the results of WP1. We will perform a cost-utility analysis of the nutritional support compared to standard routine care in cancer patients, taking a societal perspective. The generic outcome is Quality adjusted life-years (QALYs) measured by the generic instrument EQ-5D-5L. In order to generate QALYs, health utilities are needed. Utilities are preference weights, measured on a scale from 0 (dead) and 1 (full health). Data will be collected through self-reported measures and electronic patient records, and the health economic analysis will include following costs:
Intervention related costs, mainly related to intervention implementation (introduction to health care personnel and patients, maintenance (software and security updates) and personnel costs due to follow-up.
Health care costs/direct costs, mainly related to use of health care services (including primary care; general practitioner, physical therapy, psychology visits, secondary care; hospitalization, readmission, outpatient visits, use of antibiotics, enteral and parenteral nutrition products.
Societal costs/indirect costs, including work absence (i.e., productivity loss).
Study design
- Primary purpose
- Health services research
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- None (open label)
- Number of arms
- 2
- Model description
- Randomised controlled trial
| Arm | Type | Receives |
|---|---|---|
| Intervention | Experimental | Other: Diatary advicesExtra nutritional support |
| Control | No intervention | –Usual care |
Who may qualify
- Ages
- 18 years and older
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (4 listed)
- gynaecologic cancer with planned radiation therapy (ca. cervix)
- colorectal cancer
- lymphomas
Key exclusion criteria (2 listed)
- Exclusion criteria are defined as patients admitted with TNM stage 4
- Terminal condition (life expectancy < 6 months).
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Diatary advicesAlso: Usual careAdvice regarding energy, protein and nutrient intake during cancer treatment | Other | Intervention |
Primary outcome
Malnutrition
Time frame: After 6 months
Measured by PG-SGA
11 secondary outcomes
Malnutrition by GLIM
Time frame: 6 month
Other clinical outcomes
Time frame: 6 months
Survival
Time frame: 12 months
Health-related quality of life
Time frame: 6 and 12 months
Cancer specific quality of life
Time frame: 6 and 12 months
Health costs
Time frame: 12 months
Appreciation by health care professionals and patients
Time frame: 6 months
Infection rate
Time frame: 6 months
Need for antibiotics
Time frame: 6 months
Length of hospital stay
Time frame: 6 months
Re-admissions
Time frame: 6 and 12 months
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 8 Sep 2025.
- Derived from this study: PubMed 39010098Beichmann B, Henriksen C, Paur I, Paulsen MM. Barriers and facilitators of improved nutritional support for patients newly diagnosed with cancer: a pre-implementation study. BMC Health Serv Res. 2024 Jul 15;24(1):815. doi: 10.1186/s12913-024-11288-2.
- Individual participant dataSharing planned: No
Related trials for Malnutrition
RecruitingPhase 1/2
A First-in-human Study of KK8123 in Adults With X-linked Hypophosphatemia
X-linked Hypophosphatemia
Recruiting
Linking Education, Produce Provision, and Community Referrals to Improve Diabetes Care (LINK)
Diabetes Mellitus, Type 2, Nutrition Poor
Active, not recruiting
Evaluation of Personalized Nutritional Intervention on Wound Healing of Cutaneous Ulcers in Diabetics
Foot, Diabetic
Active, not recruitingPhase 2
Maternal Probiotic Intervention to Improve Gut Health-Trial II-Pakistan
Environmental Enteric Dysfunction (EED), Stunting
Not yet recruitingObservational study
Biomarkers in EV Associated With Marrow Adiposity in Anorexia
Anorexia Nervosa Restricting Type, Anorexia Nervosa (DSM-IV Revised Criteria)
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Christine Henriksen, PhD principal investigator
University of Oslo
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Diatary advices in people with Malnutrition, run by University of Oslo at 1 site in Norway.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 4 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: under way, not looking for participants, as of the sponsor's last update on 8 Sep 2025. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Norway. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Malnutrition (time frame: After 6 months). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT05544318, which also lists 1 linked publication.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 8 Sep 2025.